Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

1-(2,6-Dibenzyloxybenzoyl)-3-(9H-fluoren-9-yl)-urea: a novel cyclophilin A allosteric activator.

Biochemical and biophysical research communications - 7 Sept 2012

Lv Maosheng, Shi Ting, Mao Xiaona, Li Xi, Chen Yingyi, Zhu Jin, Ni Shuaishuai, Shen Xu, Jiang Hualiang, Li Jian, Zhang Jian, Huang Jin

Abstract excerpt

Cyclophilin A (CypA) plays an important role in many physiology processes and its overexpression has been involved in many diseases including immune disease, viral infection, neuro-degenerative disease, and cancer. However, the actual role of CypA in the diseases is still far from clear, and a complete understanding of CypA is necessary in order to direct more specific and effective therapeutic strategies. Based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allosteric Regulation
Share to Binding Sites

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclophilin A

Share to Enzyme Activation

Share to Fluorenes

Share to Protein Binding

Share to Protein Conformation

Source

Identifiers

PMID: 22906739
DOI: 10.1016/j.bbrc.2012.08.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

1-(2,6-Dibenzyloxybenzoyl)-3-(9H-fluoren-9-yl)-urea: a novel cyclophilin A allosteric activator.PMID 22906739Read ↗

Preparation, characterization and refolding in vitro of a recombinant human cyclophilin A mutant: effect of a single Pro/Ser substitution on cyclophilin A structure and properties.Semantic proximity Read ↗

Cyclophilin A: a key player for human diseaseSemantic proximity Read ↗

Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis.Semantic proximity Read ↗

Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor.Semantic proximity Read ↗

Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020).Semantic proximity Read ↗

Chemical Space Exploration and Machine Learningbased Screening of PDE7A InhibitorsSemantic proximity Read ↗

Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites.Semantic proximity Read ↗

Modulation of CIP2A dimerization and protein stability via druggable pocketSemantic proximity Read ↗

In silico analyses of essential interactions of iminosugars with the Hex A active site and evaluation of their pharmacological chaperone effects for Tay-Sachs disease.Semantic proximity Read ↗

Allosteric mechanism of cyclopropylindolobenzazepine inhibitors for HCV NS5B RdRp via dynamic correlation network analysis.Semantic proximity Read ↗

5-C-Branched Deoxynojirimycin: Strategy for Designing a 1-Deoxynojirimycin-Based Pharmacological Chaperone with a Nanomolar Affinity for Pompe Disease.Semantic proximity Read ↗

Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.